3,838 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Brendel Financial Advisors LLC

Brendel Financial Advisors LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,838 shares of the medical equipment provider's stock, valued at approximately $2,003,000.

Other large investors also recently bought and sold shares of the company. Moseley Investment Management Inc. lifted its position in Intuitive Surgical by 2.4% during the fourth quarter. Moseley Investment Management Inc. now owns 2,139 shares of the medical equipment provider's stock valued at $1,116,000 after buying an additional 51 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its holdings in Intuitive Surgical by 65.2% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,913 shares of the medical equipment provider's stock valued at $998,000 after purchasing an additional 755 shares in the last quarter. Park Avenue Securities LLC raised its position in Intuitive Surgical by 5.2% in the fourth quarter. Park Avenue Securities LLC now owns 15,724 shares of the medical equipment provider's stock valued at $8,207,000 after purchasing an additional 784 shares during the period. Assenagon Asset Management S.A. boosted its position in shares of Intuitive Surgical by 9.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,571,273 shares of the medical equipment provider's stock worth $820,142,000 after buying an additional 129,363 shares during the period. Finally, Board of the Pension Protection Fund purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $1,044,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling

In other news, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the company's stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company's stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 over the last 90 days. 0.90% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Citigroup lifted their price objective on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research report on Thursday, December 5th. Piper Sandler reiterated an "overweight" rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Finally, Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $554.17.

Intuitive Surgical Trading Up 8.3 %

Intuitive Surgical stock traded up $44.96 during midday trading on Wednesday, reaching $583.84. 2,584,494 shares of the stock traded hands, compared to its average volume of 1,488,254. The firm has a fifty day moving average price of $537.05 and a two-hundred day moving average price of $496.50. The firm has a market cap of $207.95 billion, a price-to-earnings ratio of 93.87, a PEG ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $355.17 and a fifty-two week high of $584.60.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.